Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2024-05-30 19:14 |
![]() ARUTYUNOV, G., TARLOVSKAYA, E., ARUTYUNOV, A., BELENKOV, Yu., KONRADI, Aleksandra, LOPATIN, Yu., REBROV, Andrey, TERESHCHENKO, Sergey, CHESNIKOVA, Anna, AIRAPETYAN, G., BABIN, Aleksandr, BAKULIN, I., NOI, Autori, BUDU, Angela, PETROV, Liviu. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors". In: Russian Journal of Cardiology, 2022, vol. 27, pp. 16-30. ISSN 1560-4071. DOI: https://doi.org/10.15829/1560-4071-2022-5042 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Russian Journal of Cardiology | |
Volumul 27 / 2022 / ISSN 1560-4071 | |
|
|
DOI:https://doi.org/10.15829/1560-4071-2022-5042 | |
Pag. 16-30 | |
![]() |
|
Rezumat | |
Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed]. |
|
Cuvinte-cheie cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triacylglycerol |
|
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Arutyunov, G.P.</dc:creator> <dc:creator>Tarlovskaya, E.I.</dc:creator> <dc:creator>Arutyunov, A.G.</dc:creator> <dc:creator>Belenkov, Y.N.</dc:creator> <dc:creator>Konradi, A.O.</dc:creator> <dc:creator>Lopatin, Y.M.</dc:creator> <dc:creator>Rebrov, A.P.</dc:creator> <dc:creator>Tereshchenko, S.N.</dc:creator> <dc:creator>Chesnikova, A.I.</dc:creator> <dc:creator>Airapetyan, G.G.</dc:creator> <dc:creator>Babin, A.P.</dc:creator> <dc:creator>Bakulin, I.G.</dc:creator> <dc:creator>Noi, A.</dc:creator> <dc:creator>Budu, A.M.</dc:creator> <dc:creator>Petrov, L.D.</dc:creator> <dc:date>2022-09-14</dc:date> <dc:description xml:lang='en'><p> </p><p>Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed].</p></dc:description> <dc:identifier>10.15829/1560-4071-2022-5042</dc:identifier> <dc:source>Russian Journal of Cardiology () 16-30</dc:source> <dc:subject>cholesterol</dc:subject> <dc:subject>high density lipoprotein cholesterol</dc:subject> <dc:subject>low density lipoprotein cholesterol</dc:subject> <dc:subject>triacylglycerol</dc:subject> <dc:title>Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>